Forecasting fully vaccinated people against COVID-19 and examining future vaccination rate for herd immunity in the US, Asia, Europe, Africa, South America, and the World
Özet
Coronavirus disease 2019 (COVID-2019) has spread rapidly all over the world and it is known that the most effective way to eliminate the disease is vaccination. Although the traditional vaccine development process is quite long, more than ten COVID-19 vaccines have been approved for use in about a year. The COVID-19 vaccines that have been administered are highly effective enough, but achieving herd immunity is required to end the pandemic. The motivation of this study is to contribute to review the countries’ vaccine policies and adjusting the manufacturing plans of the vaccine companies. In this study, the total number of people fully vaccinated against COVID-19 was forecasted in the US, Asia, Europe, Africa, South America, and the World with the Autoregressive Integrated Moving Average (ARIMA) model, which is a new approach in vaccination studies. Additionally, for herd immunity, the percentage of fully vaccinated people in these regions at the beginning of 2021 summer was determined. ARIMA results show that in the US, Asia, Europe, Africa, South America, and the World will reach 139 million, 109 million, 127 million, 8 million, 38 million, and 441 million people will be fully vaccinated on 1 June 2021, respectively. According to these results, 41.8% of the US, 2.3% of Asia, 17% of Europe, 0.6% of Africa, 8.8% of South America, and 5.6% of the World population will be fully vaccinated people against the COVID-19. Results show that countries are far from the herd immunity threshold level desired to reach for safely slow or stop the COVID-19 epidemic. © 2021
Cilt
111Koleksiyonlar
İlgili Öğeler
Başlık, yazar, küratör ve konuya göre gösterilen ilgili öğeler.
-
A new approach for determining SARS-CoV-2 epitopes using machine learning-based in silico methods
Cihan, Pınar; Özger, Zeynep Banu (Elsevier Ltd, 2022)The emergence of machine learning-based in silico tools has enabled rapid and high-quality predictions in the biomedical field. In the COVID-19 pandemic, machine learning methods have been used in many topics such as ... -
Immunogenicity after CoronaVac vaccination
Güzel, Eda Çelik; Çelikkol, Aliye; Erdal, Berna; Sedef, N. (Associacao Medica Brasileira, 2021)OBJECTIVE: This study aimed to investigate the seropositivity of CoronaVac-SinoVac vaccination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) risk factors and comorbidities. METHODS: Immunoglobulin (IgG) ... -
Immunization rates of pneumococcal, influenza and tetanus vaccines and knowledge and attitudes of adult patients who receive inpatient treatment at hospital: Point prevalence study
Hamidi, Aziz Ahmad; Taş, Beray Gelmez; Gündüz, Alper; Çelebi, Safiye Nur; Esen, Elif Serap; Toprak, Dilek; Dokmetas, İlyas (Taylor & Francis Inc, 2018)The safety of vaccines, access to health care, the level of community's knowledge and the attention of physicians play a critical role in the rate of adult vaccination. This study aims to determine the immunization rate ...